On August 22, 2014, the DEA issued a final rule (79 FR 49661) in which they rescheduled hydrocodone combination products (HCPs) from schedule III to schedule II of the Controlled Substances Act as of October 6, 2014.
Partnership Forum: On September 9, 2014, AMCP convened a meeting of multiple stakeholders to recommend activities and programs that AMCP can promote to improve pain management, prevent opioid use disorder (OUD), and improve medication-assisted treatment outcomes.
Project description, implementation overview, schedule and program documents for the 2014 Mercer University Student Symposium hosted by Mercer University.